Amniotic mesenchymal stem cells attenuate diabetic cardiomyopathy by inhibiting pyroptosis via modulation of the TLR4/NF-κb/NLRP3 pathway. The gene discussed is TLR4; the disease is diabetic cardiomyopathy.